Combating Undetected Lung Inflammation in Patients with an Autoimmune Disorder (2 of 2) (IMAGE)

American Association for the Advancement of Science (AAAS)

Combating Undetected Lung Inflammation in Patients with an Autoimmune Disorder (2 of 2)

Caption

Modulating the activity of B and T cells improved pneumonitis in patients with APECED after one month (middle panel) and six months (right panel) of treatment. This material relates to a paper that appeared in the Jun. 5, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by E. Ferré at National Institute of Allergy and Infectious Diseases (NIAID), NIH in Bethesda, MD; and colleagues was titled, "Lymphocyte-driven regional immunopathology in pneumonitis that is caused by impaired central immune tolerance."

Credit

E. Ferré <i>et al., Science Translational Medicine</i> (2019)

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.